Open AccessHAART with didanosine once versus twice daily: adherence and efficacy
Author(s) -
Bernardino Roca,
Consol Lapuebla,
B. Vidal
Publication year - 2005
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2004.07.006
Subject(s) - didanosine , medicine , regimen , prospective cohort study , human immunodeficiency virus (hiv) , cohort , antiretroviral therapy , viral load , immunology
Highly active antiretroviral therapy (HAART) containing didanosine taken twice daily was compared with HAART containing didanosine taken once daily in terms of adherence and efficacy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom